Milestones 2007

Full reporting of Phase 1 clinical trial with HPH116 (50 heathly volunteers)

Full reporting of Phase 1 clinical trial Food Drug Interaction (12 healthly volunteers)

Submission to the FDA of an IND request


Scientific Advisory Board

Full reporting of six months toxicology study in rats


18 months stability report for Active Product Ingredient and Capsules
Labima Laboratories collaboration


Meeting with Investagator Centers in Spain
600 mg capsules for clinical trial "Proof of Concept"

Agreement of the Ethical Committees from the six centers in Spain


Responses to Spanih Authorities
Designation of a central laboratory for CD4 counts and Viral Load


EudraCT annual reporting on Adverse Evens
Follow up Study “Proof of Concept”


Capital increase up to 8.3500.000€
   

Milestones 2008

   

24 months dog toxicology study


Phase I/II double blind study 36 patients

6 clinical center Spain


New shareholding

GCP,GLP,GMP therapeutic vaccine preparation

 

Milestones 2009


Peparation of clinical phase II therapeutic vaccine

New patent covering therapeutic vaccine applications

 

 

Milestones 2015

Publication of full data dossier

Research of an External Partner

Time For New Management

 

 
 
 
H-Phar™ and the H-Phar logo are registred trademarks of H-Phar Company™